5-BrdU

SKU: orb1300459

Description

5-BrdU

Research Area

Cell Biology, Molecular Biology

Key Properties

• CAS Number: 59-14-3
• MW: 307.1
• Purity: 99.54%
• Formula: C₉H₁₁BrN₂O₅
• SMILES: O=C1N([C@@H]2O[C@H](CO)[C@@H](O)C2)C=C(Br)C(=O)N1
• Target: Nucleoside Antimetabolite/Analog,DNA/RNA Synthesis
• Solubility: Ethanol:2 mg/mL (6.51 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (16.28 mM);DMSO:242.5 mg/mL (789.65 mM);H2O:15.4 mg/mL (50.15 mM)

Bioactivity

• Target IC50:
  T24 cells (24 h):47 μM|HepG2 cells (24 h):11 μM|HepG2 cells:7.8 μM|L5178Y cells:20 μM|T24 cells (48 h):17 μM
• In Vivo:
  METHODS: To stud the anti-tumor activity of 5-BrdU, 5-BrdU was intraperitoneally injected (300 mg/kg) or orally administered (0.8 mg/mL) in the rat glioma RG2 tumor model. Results: 5-BrdU significantly slowed dow the progression o the tumor. METHODS: To stud the effect of exposure durin the embryonic period o the cerebellar neuroepithelium of mice, pregnant rats were injected with different doses (25-300 µg/g) of 5-BrdU at a Single time o the 13th day o the embryo. Results: Low doses (25-75 µg/g) of 5-BrdU did not chang the proliferation behavior of cerebellar neuroepithelial cells, while high doses (100-300 µg/g) led to a decrease in related proliferation parameters, among whic the effect o the 300 µg/g dose wa the most significant. METHODS: To stud the effect of 5-BrdU on neuroblasts in the granular layer outsid the cerebellum of mice, different doses (50-300 µg/g) of 5-BrdU were injected once o the 9th day afte the birth of mice. Results: Different doses of 5-BrdU can affec the duration of Each stage o the cell cycle an the completion time o the entire cell cycle. METHODS: To investigat the effect of 5-BrdU on neurogenesis in the hippocampal dentate gyrus of adult rats, adult rats were treated with cumulative doses of 5-BrdU (40, 240 or 460 mg/kg). Results: 5-BrdU did not reduce cell proliferation o the number of immature neurons in the dentate gyrus o the hippocampus.
• In Vitro:
  METHODS: Mouse neural precursor cells were treated with 5-BrdU, an the cell proliferation activity was detected by MTT. Results the EC50 value o the anti-proliferation activity of 5-BrdU was 2.04 μM. METHODS: L5178Y mouse leukemia cells were treated with 5-BrdU, an the growth Inhibition o the cells was determined by growth inhibition. Results: In L5178Y mouse leukemia cells the IC50 Values of 5-BrdU were 2 μM (determined by [14C] leucine incorporation) and 2 μM (determined by [14C] thymidine incorporation), respectively
• Cell Research:
  Cultures are initially plated at 2000 cells/cm2 and are quantified with a Z2 Coulter Counter. RG2 rat glioma cells are treated once with 0, 1, 10, or 50 μM BrdU for 24 hours, and cumulative growth curves were obtained over 18 days. Control and treated cells are quantified and replated at equal densities on days 5, 12, and 18 after treatment.(Only for Reference)

Storage & Handling

• Storage: keep away from direct sunlight,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Disclaimer: For research use only

Alternative Names

Broxuridine, Bromodeoxyuridine, BUdR, Analog, 5-bromo-2'-deoxyuridine, 5BrdU, 5-BrdU, 5 BrdU, BRDU, inhibit, Nucleoside Antimetabolite, NucleosideAntimetabolite, Nucleoside Antimetabolite/Analog, Inhibitor

Compound Identifiers

PubChem CID

6035